Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Hipertens Riesgo Vasc ; 37(1): 11-16, 2020.
Artículo en Español | MEDLINE | ID: mdl-31405823

RESUMEN

OBJECTIVE: To analyse the outcomes of a motivational physical activity program for the treatment of obesity. METHOD: A randomised, controlled, double blind clinical trial with 2 arms, 12 months of follow-up and a 1:1 allocation ratio. The data was collected between July 2017 and July 2018. The patients, of both genders, had to be referred by their occupational medicine doctors with the diagnosis of overweight or obesity and be aged between 20 and 65 years. An analysis was made of the anthropometric measurements, lipid parameters, as well as on the follow-up of the program. RESULTS: A total of 123 obese or overweight patients participated. Two groups were formed; 61 in intervention group [G1] and 62 in as usual care control group [G2]). As regards the 107 that finished the study (60 in G1 and 47 in G2), the mean age was 45.55±12.83 SD, with 57.2% women and 42.8% men. The number of patients followed-up was much higher in the Physical Activity Program than in the control group, and the number of dropouts (only one) was insignificant. It can be seen how both the weight and the body mass index as the main lipid parameters are reduced in the study group significantly with respect to the control group. The physical activity of the group in the motivated physical activity program is three times higher than in the group without intervention. There was a significant relationship between the increase in activity and weight reduction (P<.001), also between the reduction in weight and the reduction in cholesterol and triglycerides. CONCLUSIONS: In our study, a motivational physical activity program leads to more follow-up and therefore improves the anthropometric and lipid parameters.


Asunto(s)
Ejercicio Físico/psicología , Motivación , Obesidad/terapia , Sobrepeso/terapia , Adulto , Método Doble Ciego , Femenino , Estudios de Seguimiento , Humanos , Lípidos/sangre , Masculino , Persona de Mediana Edad , Obesidad/psicología , Sobrepeso/psicología , Pérdida de Peso/fisiología
2.
Semergen ; 44(4): 249-256, 2018.
Artículo en Español | MEDLINE | ID: mdl-28645694

RESUMEN

OBJECTIVE: To determine whether or not nicotine addiction treatment was less effective in psychiatric than in the healthy population. MATERIAL AND METHODS: A retrospective, descriptive and comparative cohort study was conducted in Albacete University Hospital during years 2008-2012 on all patients that attended the Tobacco Cessation Unit. The statistical tests used were Chi-squared, likelihood ratio, and the Student t test. Statistical significance P≤.05. RESULTS: The study included a total of 1,484 patients, of which 48.6% were female. The mean age was 46.8 years, and the mean age of starting smoking was 17.6 years. The mean number of previous attempts to quit was 1.48, and mean number of cigarettes smoked was 25.39. They had a mean Fagerström score of 6.04, a Richmond score of 8.13, and a mean carbon monoxide level of 16.65ppm. Most patients were referred from Primary Care (38.7%) and Chest Diseases department (33%), and the type of tobacco smoked was "light" in 75.8%. There was 15% with chronic obstructive pulmonary disease, 8% with asthma, and 9.4% with obstructive sleep apnoea syndrome. Furthermore, there was respiratory disease in 28.7%, cardiovascular disease in 4.6%, and both in 3.5%. Hiatus hernia was present in 7.2%, thyroid disease in 3.8%, hypertension in 19%, diabetes in 10.7%, and dyslipidaemia in 29.4%, Drugs were used by 7.1%, and 12.6% consumed alcohol. There was 39.3% psychiatric comorbidity (PC), and were comparable except in gender, age of onset, Fagerström, Richmond, source of referral, asthma, hiatus hernia, thyroid disease, hypertension, as well as drugs and treatment. Drug treatment was completed by 22.3% in the PC group, with no significant difference. There were differences in success (P=.008), but not in failure and relapse rates. CONCLUSION: Anti-smoking treatment in psychiatric patients is effective. An increase in the probability of treatment success is observed in patients without psychiatric comorbidity.


Asunto(s)
Trastornos Mentales/complicaciones , Cese del Hábito de Fumar/métodos , Prevención del Hábito de Fumar/métodos , Tabaquismo/rehabilitación , Adulto , Monóxido de Carbono/metabolismo , Estudios de Cohortes , Humanos , Masculino , Trastornos Mentales/epidemiología , Persona de Mediana Edad , Estudios Retrospectivos , Fumar/epidemiología , España , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA